认知功能的损伤增加了死亡风险与心脏交感性缩和脏功能障碍在患有系统性心力衰竭的患者
Mirei Nabuchi1, Takahiro Doi1, Ryosuke Hatano1
1Department of Cardiology, Teine Keijinkai Hospita.
概括
认知障碍,心脏交感功能减弱和功能不良独立地预测心力衰竭 (HF) 患者的心脏事件. 这些因素协同增加HF患者的死亡风险.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 建立了心脏和脏相互作用的预后意义.
- 认知障碍对心脏预后的影响,特别是对心脏交感内置和心力衰竭 (HF) 患者的功能的影响,仍然不清楚.
研究的目的:
- 研究认知功能,心交感内置和功能对心力衰竭患者心脏预后的独立和联合影响.
主要方法:
- 433名高压患者 (LVEF <50%) 接受了认知查 (迷你精神状态检查 (MMSE) 和神经心理测试).
- 心脏交感内置被评估使用metaliodobenzylguanidine (MIBG) 剪影 (标准化心脏与中介质的比率[sHMR]).
- 通过估计的淋巴细胞过率 (eGFR) 评估功能;致命的心脏事件 (CEs) 被跟踪了14.8个月.
主要成果:
- 在84名患者中发生了CE.
- 患有CE的患者的MMSE得分,eGFR和sHMR都明显较低.
- 多变量分析确定了MMSE得分,eGFR和sHMR作为CE的独立预测因素.
- 在ROC分析中发现了CE风险增加的切线值 (MMSE <26,sHMR <1.80,eGFR <47.0 mL/min/1.73 m2).
结论:
- 认知功能受损是HF患者心脏病死亡率的独立预测因素.
- 认知障碍协同增加心脏死亡风险,与心脏交感功能和功能受损相结合.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
Disorders of the Autonomic Nervous System
605
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
605
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336


